nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Meningism—Methotrexate—lymphatic system cancer	0.0321	0.0321	CcSEcCtD
Procaine—Arachnoiditis—Methotrexate—lymphatic system cancer	0.0305	0.0305	CcSEcCtD
Procaine—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.0233	0.0233	CcSEcCtD
Procaine—Neuropathy—Teniposide—lymphatic system cancer	0.0201	0.0201	CcSEcCtD
Procaine—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.0172	0.0172	CcSEcCtD
Procaine—Paralysis—Vincristine—lymphatic system cancer	0.0165	0.0165	CcSEcCtD
Procaine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Procaine—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Procaine—Nephropathy—Methotrexate—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Procaine—Sweating increased—Fludarabine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Procaine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Procaine—Neuropathy—Carmustine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Procaine—Disorientation—Bleomycin—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Procaine—Neuropathy—Vincristine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Procaine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Procaine—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Procaine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Procaine—Chills—Teniposide—lymphatic system cancer	0.00963	0.00963	CcSEcCtD
Procaine—Eruption—Methotrexate—lymphatic system cancer	0.00905	0.00905	CcSEcCtD
Procaine—Agitation—Teniposide—lymphatic system cancer	0.00859	0.00859	CcSEcCtD
Procaine—Chills—Fludarabine—lymphatic system cancer	0.00846	0.00846	CcSEcCtD
Procaine—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00838	0.00838	CcSEcCtD
Procaine—Leukopenia—Teniposide—lymphatic system cancer	0.00836	0.00836	CcSEcCtD
Procaine—Hypertension—Teniposide—lymphatic system cancer	0.00807	0.00807	CcSEcCtD
Procaine—Paralysis—Methotrexate—lymphatic system cancer	0.00801	0.00801	CcSEcCtD
Procaine—Cardiac arrest—Vincristine—lymphatic system cancer	0.00792	0.00792	CcSEcCtD
Procaine—Oedema—Teniposide—lymphatic system cancer	0.00762	0.00762	CcSEcCtD
Procaine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00762	0.00762	CcSEcCtD
Procaine—Agitation—Fludarabine—lymphatic system cancer	0.00755	0.00755	CcSEcCtD
Procaine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00747	0.00747	CcSEcCtD
Procaine—Tachycardia—Teniposide—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Procaine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00737	0.00737	CcSEcCtD
Procaine—Leukopenia—Fludarabine—lymphatic system cancer	0.00735	0.00735	CcSEcCtD
Procaine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00732	0.00732	CcSEcCtD
Procaine—Hypotension—Teniposide—lymphatic system cancer	0.00712	0.00712	CcSEcCtD
Procaine—Convulsion—Fludarabine—lymphatic system cancer	0.00711	0.00711	CcSEcCtD
Procaine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00708	0.00708	CcSEcCtD
Procaine—Arthralgia—Fludarabine—lymphatic system cancer	0.00699	0.00699	CcSEcCtD
Procaine—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00683	0.00683	CcSEcCtD
Procaine—Oedema—Fludarabine—lymphatic system cancer	0.0067	0.0067	CcSEcCtD
Procaine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0067	0.0067	CcSEcCtD
Procaine—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00659	0.00659	CcSEcCtD
Procaine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00658	0.00658	CcSEcCtD
Procaine—Apnoea—Methotrexate—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Procaine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00656	0.00656	CcSEcCtD
Procaine—Rash—Mechlorethamine—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Procaine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00651	0.00651	CcSEcCtD
Procaine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00648	0.00648	CcSEcCtD
Procaine—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Procaine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00625	0.00625	CcSEcCtD
Procaine—Chills—Bleomycin—lymphatic system cancer	0.00621	0.00621	CcSEcCtD
Procaine—Nausea—Mechlorethamine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Procaine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Procaine—Urticaria—Teniposide—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Procaine—Body temperature increased—Teniposide—lymphatic system cancer	0.00603	0.00603	CcSEcCtD
Procaine—Erythema—Bleomycin—lymphatic system cancer	0.00602	0.00602	CcSEcCtD
Procaine—Hallucination—Carmustine—lymphatic system cancer	0.00601	0.00601	CcSEcCtD
Procaine—Fatigue—Fludarabine—lymphatic system cancer	0.00578	0.00578	CcSEcCtD
Procaine—Hallucination—Vincristine—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Procaine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Procaine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00562	0.00562	CcSEcCtD
Procaine—Pruritus—Teniposide—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Procaine—Leukopenia—Bleomycin—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Procaine—Body temperature increased—Fludarabine—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Procaine—Erythema—Carmustine—lymphatic system cancer	0.00525	0.00525	CcSEcCtD
Procaine—Diarrhoea—Teniposide—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Procaine—Chills—Mitoxantrone—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Procaine—Vision blurred—Carmustine—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Procaine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00494	0.00494	CcSEcCtD
Procaine—Tremor—Carmustine—lymphatic system cancer	0.00492	0.00492	CcSEcCtD
Procaine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Procaine—Oedema—Bleomycin—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Procaine—Erythema—Mitoxantrone—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Procaine—Vomiting—Teniposide—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Procaine—Agitation—Carmustine—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Procaine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Procaine—Rash—Teniposide—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Procaine—Dermatitis—Teniposide—lymphatic system cancer	0.0048	0.0048	CcSEcCtD
Procaine—Pruritus—Fludarabine—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Procaine—Leukopenia—Carmustine—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Procaine—Agitation—Vincristine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Procaine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Procaine—Hypotension—Bleomycin—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Procaine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Procaine—Convulsion—Carmustine—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Procaine—Hypertension—Carmustine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Procaine—Nausea—Teniposide—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Procaine—Leukopenia—Vincristine—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Procaine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Procaine—Anxiety—Carmustine—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Procaine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Procaine—Convulsion—Vincristine—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Procaine—Hypertension—Vincristine—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Procaine—Oedema—Carmustine—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Procaine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Procaine—Vomiting—Fludarabine—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Procaine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Procaine—Rash—Fludarabine—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Procaine—Dermatitis—Fludarabine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Procaine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Procaine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Procaine—Tachycardia—Carmustine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Procaine—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Procaine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Procaine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Procaine—Oedema—Vincristine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Procaine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Procaine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00401	0.00401	CcSEcCtD
Procaine—Hypotension—Carmustine—lymphatic system cancer	0.00401	0.00401	CcSEcCtD
Procaine—Oedema—Mitoxantrone—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Procaine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Procaine—Nausea—Fludarabine—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Procaine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Procaine—Shock—Mitoxantrone—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Procaine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Procaine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Procaine—Urticaria—Bleomycin—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Procaine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Procaine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Procaine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Procaine—Hypotension—Vincristine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Procaine—Somnolence—Carmustine—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Procaine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Procaine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Procaine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Procaine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Procaine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Procaine—Fatigue—Vincristine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Procaine—Pruritus—Bleomycin—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Procaine—Eosinophilia—Methotrexate—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Procaine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Procaine—Body temperature increased—Carmustine—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Procaine—Body temperature increased—Vincristine—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Procaine—Urticaria—Mitoxantrone—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Procaine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Procaine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Procaine—Vomiting—Bleomycin—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Procaine—Drowsiness—Methotrexate—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Procaine—Rash—Bleomycin—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Procaine—Dermatitis—Bleomycin—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Procaine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Procaine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Procaine—Diarrhoea—Carmustine—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Procaine—Nausea—Bleomycin—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Procaine—Dizziness—Carmustine—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Procaine—Diarrhoea—Vincristine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Procaine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Procaine—Vomiting—Carmustine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Procaine—Dizziness—Vincristine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Procaine—Rash—Carmustine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Procaine—Dermatitis—Carmustine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Procaine—Tinnitus—Methotrexate—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Procaine—Vomiting—Vincristine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Procaine—Rash—Vincristine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Procaine—Dermatitis—Vincristine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Procaine—Nausea—Carmustine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Procaine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Procaine—Rash—Mitoxantrone—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Procaine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Procaine—Chills—Methotrexate—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Procaine—Erythema—Methotrexate—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Procaine—Nausea—Vincristine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Procaine—Nausea—Mitoxantrone—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Procaine—Vision blurred—Methotrexate—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Procaine—Leukopenia—Methotrexate—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Procaine—Convulsion—Methotrexate—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Procaine—Arthralgia—Methotrexate—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Procaine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Procaine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Procaine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Procaine—Hypotension—Methotrexate—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Procaine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Procaine—Somnolence—Methotrexate—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Procaine—Fatigue—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Procaine—Urticaria—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Procaine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Procaine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Procaine—Pruritus—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Procaine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Procaine—Dizziness—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Procaine—Vomiting—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Procaine—Rash—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Procaine—Dermatitis—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Procaine—Nausea—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
